$SCYX Cashflow Statement | Understand Stock

$SCYX

$3.95 +$0.15 (3.95%) Close

$SCYX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
Accretion of investment discount
Amortization of debt issuance costs and discount
Change in fair value of warrant liabilities
Change in fair value of derivative liability
Noncash operating lease expense for right-of-use asset
Inventory impairment expense
Write off of deferred asset for commitment fees
Prepayment fee for loan payable payment
Loss on extinguishment of debt
Noncash consideration associated with common stock purchase agreement
Changes in operating assets and liabilities:
Prepaid expenses and other current assets, deferred costs, and other
License agreement contract asset
License agreement receivable
Accounts receivable
Inventory
Accounts payable
Accrued expenses, other liabilities, and other
Accrued expenses
Deferred revenue
Other liabilities and other

Net cash used in operating activities
Cash flows from investing activities:
Maturities of investments
Purchases of property and equipment
Purchase of intangible assets
Purchase of investments
Maturity of investments
Net cash provided by investing activities

Cash flows from financing activities:
Proceeds from common stock issued
Payments of offering costs and underwriting discounts and commissions
Proceeds from loan payable
Payments of loan payable issuance costs
Payment of convertible debt
Payments of deferred offering costs
Payments of loan payable
Payment of loan payable prepayment fee
Proceeds from employee stock purchase plan issuances
Repurchase of shares to satisfy tax withholdings
Proceeds from senior convertible notes
Payments of senior convertible notes issuance costs
Net cash used in financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental cash flow information:
Cash paid for interest
Cash received for interest
Noncash financing and investing activities:
Purchased intangible assets included in accounts payable and accrued expenses
Deferred offering and issuance costs included in accounts payable
Deferred offering costs reclassified to additional paid-in capital
Common stock issued for settlement of senior convertible notes
Common stock issued for Commitment Shares
Reclass of warrant liability to additional paid in capital
Reclass of deferred asset associated with issuance of loan payable to debt discount
Settlement of liability for exercise of warrants

Comments